A multinational clinical trial has revealed that administering larger initial doses of drugs to heart failure patients drastically reduces mortality rates and lowers hospital readmission risks. St George's Hospital and Morriston Hospital are pioneering this innovative treatment in the UK. Evidence indicates that the new method has reduced deaths by nearly two-thirds and the chance of returning to the hospital by 30%. With heart failure affecting one million individuals in the UK, this advancement represents a significant shift in treatment strategies and could potentially save countless lives.
Britons with heart failure are being given larger doses of drugs at the start of their treatment after a global trial found this drastically cut deaths.
The treatment has cut deaths by nearly two-thirds and lowered their risk of returning to hospital by 30 per cent.
Collection
[
|
...
]